Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Tofacitinib (L04Aa29) As Part Of A So-Called Open House Model.

AOK Rhineland-Palatinate Saarland - The health insurance company Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Tofacitinib (L04Aa29) As Part Of A So-Called Open House Model. in Pharmaceuticals. The tender was released on Mar 18, 2023.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Tofacitinib (L04Aa29) As Part Of A So-Called Open House Model.

Deadline - Feb 28, 2025

GT reference number - 63500552

Product classification - Pharmaceutical products